178 related articles for article (PubMed ID: 24363808)
1. Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration.
Davies MA; Phiri S; Wood R; Wellington M; Cox V; Bolton-Moore C; Timmerman V; Moultrie H; Ndirangu J; Rabie H; Technau K; Giddy J; Maxwell N; Boulle A; Keiser O; Egger M; Eley B;
PLoS One; 2013; 8(12):e81037. PubMed ID: 24363808
[TBL] [Abstract][Full Text] [Related]
2. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.
Panayidou K; Davies MA; Anderegg N; Egger M;
J Int AIDS Soc; 2018 Nov; 21(11):e25200. PubMed ID: 30614622
[TBL] [Abstract][Full Text] [Related]
3. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
[TBL] [Abstract][Full Text] [Related]
4. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
5. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
[TBL] [Abstract][Full Text] [Related]
6. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
7. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
8. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017.
Iyun V; Technau KG; Eley B; Rabie H; Boulle A; Fatti G; Egger M; Tanser F; Wood R; Fairlie L; Cotton MF; Davies MA
Pediatr Infect Dis J; 2020 Feb; 39(2):127-133. PubMed ID: 31725119
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
[TBL] [Abstract][Full Text] [Related]
10. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.
Jesson J; Ephoevi-Ga A; Desmonde S; Ake-Assi MH; D'Almeida M; Sy HS; Malateste K; Amorissani-Folquet M; Dicko F; Kouadio K; Renner L; Leroy V;
Trop Med Int Health; 2019 Jun; 24(6):775-785. PubMed ID: 30945378
[TBL] [Abstract][Full Text] [Related]
11. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA).
Giles ML; Achhra AC; Abraham AG; Haas AD; Gill MJ; Lee MP; Luque M; McGowan C; Cornell M; Braitstein P; de Rekeneire N; Becquet R; Wools-Kaloustian K; Law M
J Int AIDS Soc; 2018 Jun; 21(6):e25149. PubMed ID: 29956882
[TBL] [Abstract][Full Text] [Related]
12. Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018.
Adedimeji AA; Hoover DR; Shi Q; Kim HY; Brazier E; Ross J; Murenzi G; Twizere C; Lelo P; Nsonde D; Ajeh R; Dzudie A; Nash D; Yotebieng M; Anastos K;
J Int AIDS Soc; 2021 Jun; 24(6):e25672. PubMed ID: 34152663
[TBL] [Abstract][Full Text] [Related]
13. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA;
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185
[TBL] [Abstract][Full Text] [Related]
14. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.
Schomaker M; Davies MA; Malateste K; Renner L; Sawry S; N'Gbeche S; Technau KG; Eboua F; Tanser F; Sygnaté-Sy H; Phiri S; Amorissani-Folquet M; Cox V; Koueta F; Chimbete C; Lawson-Evi A; Giddy J; Amani-Bosse C; Wood R; Egger M; Leroy V;
Epidemiology; 2016 Mar; 27(2):237-46. PubMed ID: 26479876
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa.
Adedimeji A; Edmonds A; Hoover D; Shi Q; Sinayobye JD; Nduwimana M; Lelo P; Nash D; Anastos K; Yotebieng M
PLoS One; 2017; 12(1):e0169871. PubMed ID: 28081230
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.
Porter M; Davies MA; Mapani MK; Rabie H; Phiri S; Nuttall J; Fairlie L; Technau KG; Stinson K; Wood R; Wellington M; Haas AD; Giddy J; Tanser F; Eley B
J Acquir Immune Defic Syndr; 2015 Aug; 69(5):593-601. PubMed ID: 26167620
[TBL] [Abstract][Full Text] [Related]
17. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.
Schomaker M; Leroy V; Wolfs T; Technau KG; Renner L; Judd A; Sawry S; Amorissani-Folquet M; Noguera-Julian A; Tanser F; Eboua F; Navarro ML; Chimbetete C; Amani-Bosse C; Warszawski J; Phiri S; N'Gbeche S; Cox V; Koueta F; Giddy J; Sygnaté-Sy H; Raben D; Chêne G; Davies MA;
Int J Epidemiol; 2017 Apr; 46(2):453-465. PubMed ID: 27342220
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency.
Boettiger DC; Law MG; Sohn AH; Davies MA; Wools-Kaloustian K; Leroy V; Yotebieng M; Vinikoor M; Vreeman R; Amorissani-Folquet M; Edmonds A; Fatti G; Batte J; Renner L; Adedimeji A; Kariminia A;
J Pediatric Infect Dis Soc; 2019 Nov; 8(5):450-460. PubMed ID: 30215763
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012-2017) Based on Evolving National Policies in Rural Mozambique.
Arinze F; Gong W; Green AF; De Schacht C; Carlucci JG; Silva W; Claquin G; Tique JA; Stefanutto M; Graves E; Van Rompaey S; Alvim MFS; Tomo S; Moon TD; Wester CW
AIDS Res Hum Retroviruses; 2020 Jan; 36(1):39-47. PubMed ID: 31359762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
